Reports from Shanghai University of Traditional Chinese Medicine Highlight Recent Findings in Xenografts (Establishment of Patient-derived Xenograft Mouse Model With Human Osteosarcoma Tissues).

A recent report from the Shanghai University of Traditional Chinese Medicine discusses the establishment of a patient-derived xenograft (PDX) mouse model for studying osteosarcoma, the most common primary malignant bone tumor in children and adolescents. The PDX model accurately mirrors the morphological features of human osteosarcoma and can be used to study the growth, drug resistance, relapse, and metastasis of the disease. Additionally, the model aids in screening target therapeutics and establishing personalized treatment schemes. This research provides valuable insights for improving the prognosis of osteosarcoma patients. [Extracted from the article]

Copyright of Clinical Oncology Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)